| 12820320 | Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. | Anticancer Res | 2003 Mar-Apr | Schneider J | - |
| 12820312 | Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. | Anticancer Res | 2003 Mar-Apr | Hardt PD | - |
| 22864959 | Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer. | Cancer | 2013 Feb 1 | Dhar DK | doi: 10.1002/cncr.27611 |
| 19820423 | Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer. | Pancreas | 2010 Mar | Joergensen MT | doi: 10.1097/MPA.0b013e3181bae8ab. |
| 25070887 | Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis. | J Biol Chem | 2014 Sep 12 | Li L | doi: 10.1074/jbc.M114.576934 |
| 17406361 | Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients. | Br J Cancer | 2007 May 7 | Haug U | - |
| 27573352 | TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. | Int J Oncol | 2016 Sep | Liang F | doi: 10.3892/ijo.2016.3599 |
| 29394289 | Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2. | PLoS One | 2018 Feb 2 | Shankar Babu M | doi: 10.1371/journal.pone.0191419 |
| 25818238 | MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. | Cancer Lett | 2015 Jul 10 | Taniguchi K | doi: 10.1016/j.canlet.2015.03.026 |
| 18789002 | Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. | Biochem J | 2009 Jan 1 | Thangaraju M | doi: 10.1042/BJ20081132. |
| 15996096 | Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. | Biochemistry | 2005 Jul 12 | Dombrauckas JD | - |
| 26926077 | Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer. | Sci Rep | 2016 Mar 1 | Huang L | doi: 10.1038/srep22449. |
| 22627140 | Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level. | Biochem Biophys Res Commun | 2012 Jun 22 | Kwon OH | doi: 10.1016/j.bbrc.2012.05.063 |
| 25649613 | Knockdown of PKM2 Enhances Radiosensitivity of Non-small cell Lung Cancer. | Cell Biochem Biophys | 2015 Sep | Wang S | doi: 10.1007/s12013-015-0567-y. |
| 23267074 | M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. | Proc Natl Acad Sci U S A | 2013 Jan 8 | Cort??s-Cros M | doi: 10.1073/pnas.1212780110 |
| 27014756 | Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort. | J Gastrointestin Liver Dis | 2016 Mar | Bond AD | doi: 10.15403/jgld.2014.1121.251.m2p. |
| 26092770 | KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. | Angiogenesis | 2015 Oct | Ma T | doi: 10.1007/s10456-015-9475-4 |
| 24658033 | HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells. | PLoS One | 2014 Mar 21 | Huang L | doi: 10.1371/journal.pone.0092949 |
| 26787900 | SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. | Proc Natl Acad Sci U S A | 2016 Feb 2 | Bhardwaj A | doi: 10.1073/pnas.1520045113 |
| 22271574 | Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression. | J Exp Med | 2012 Feb 13 | Goldberg MS | doi: 10.1084/jem.20111487 |
| 26500118 | PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma. | Dig Dis Sci | 2016 Mar | Li C | doi: 10.1007/s10620-015-3931-2 |
| 24120138 | PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. | Cell | 2013 Oct 10 | Israelsen WJ | doi: 10.1016/j.cell.2013.09.025. |
| 28346425 | CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma. | Oncogene | 2017 Jul 20 | Shang Y | doi: 10.1038/onc.2017.31 |
| 28869444 | Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients. | Cancer Biomark | 2017 Aug 23 | El-Abd E | doi: 10.3233/CBM-160482. |
| 28067230 | Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23. | Nat Commun | 2017 Jan 9 | Wei Y | doi: 10.1038/ncomms14041. |
| 30257458 | The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells. | Int J Mol Sci | 2018 Sep 25 | Kurihara-Shimomura M | doi: 10.3390/ijms19102907. |
| 22824010 | Emerging roles of PKM2 in cell metabolism and cancer progression. | Trends Endocrinol Metab | 2012 Nov | Luo W | doi: 10.1016/j.tem.2012.06.010 |
| 25732087 | Secreted pyruvate kinase M2 facilitates cell migration via PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells. | Biochem Biophys Res Commun | 2015 Apr 3 | Yang P | doi: 10.1016/j.bbrc.2015.02.112 |
| 26493994 | PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway. | Tumour Biol | 2016 Mar | Zhao Z | doi: 10.1007/s13277-015-4121-8 |
| 23846818 | Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer. | J Clin Endocrinol Metab | 2013 Sep | Feng C | doi: 10.1210/jc.2012-4258 |
| 17414054 | Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis. | Pancreas | 2007 Apr | Goonetilleke KS | - |
| 22807066 | Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells. | IUBMB Life | 2012 Sep | Zhou CF | doi: 10.1002/iub.1066 |
| 22052977 | Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. | Science | 2011 Dec 2 | Anastasiou D | doi: 10.1126/science.1211485 |
| 28259998 | Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells. | Oncol Rep | 2017 Apr | Guo CY | doi: 10.3892/or.2017.5438 |
| 29540198 | Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer. | World J Surg Oncol | 2018 Mar 14 | Bandara IA | doi: 10.1186/s12957-018-1360-3. |
| 29514980 | Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma. | J Biol Chem | 2018 Apr 27 | Zhao X | doi: 10.1074/jbc.RA117.000100 |
| 25233397 | PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer. | Br J Cancer | 2014 Oct 28 | Papadaki C | doi: 10.1038/bjc.2014.492 |
| 25703326 | Regulatory circuit of PKM2/NF-??B/miR-148a/152-modulated tumor angiogenesis and cancer progression. | Oncogene | 2015 Oct | Xu Q | doi: 10.1038/onc.2015.6 |
| 26158845 | The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer. | PLoS One | 2015 Jul 9 | Sithambaram S | doi: 10.1371/journal.pone.0131616 |
| 26506517 | The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells. | Oncotarget | 2015 Nov 10 | Liang YC | doi: 10.18632/oncotarget.5710. |
| 26183399 | Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread. | Oncotarget | 2015 Sep 15 | Giannoni E | - |
| 25661370 | Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture. | Biomed Pharmacother | 2015 Feb | Dong T | doi: 10.1016/j.biopha.2014.12.010 |
| 23793810 | PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer. | Clin Transl Oncol | 2014 Feb | Li J | doi: 10.1007/s12094-013-1063-8 |
| 26702927 | The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation. | Oncotarget | 2015 Dec 29 | Altuntas S | doi: 10.18632/oncotarget.6759. |
| 27012213 | PKM1 is involved in resistance to anti-cancer drugs. | Biochem Biophys Res Commun | 2016 Apr 22 | Taniguchi K | doi: 10.1016/j.bbrc.2016.03.074 |
| 23086999 | SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. | Science | 2012 Nov 23 | Keller KE | doi: 10.1126/science.1224409 |
| 26405201 | Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor. | Nucleic Acids Res | 2016 Jan 29 | Matsuda S | doi: 10.1093/nar/gkv967 |
| 25313085 | Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition. | Proc Natl Acad Sci U S A | 2014 Oct 28 | Hamabe A | doi: 10.1073/pnas.1407717111 |
| 24077665 | Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. | Oncotarget | 2014 Sep 30 | Desai S | - |
| 20332442 | Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer. | Anticancer Res | 2010 Feb | Landt S | - |
| 24508027 | PKM2 contributes to cancer metabolism. | Cancer Lett | 2015 Jan 28 | Wong N | doi: 10.1016/j.canlet.2014.01.031 |
| 26464675 | Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer. | Int J Clin Exp Pathol | 2015 Aug 1 | Gao Y | - |
| 24492614 | Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner. | J Biol Chem | 2014 Mar 21 | Iqbal MA | doi: 10.1074/jbc.M113.515742 |
| 25411978 | PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways. | Mol Med Rep | 2015 Mar | Feng J | doi: 10.3892/mmr.2014.2990 |
| 19754967 | Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasia. | BMC Cancer | 2009 Sep 15 | Aloysius MM | doi: 10.1186/1471-2407-9-327. |
| 20847263 | Evidence for an alternative glycolytic pathway in rapidly proliferating cells. | Science | 2010 Sep 17 | Vander Heiden MG | doi: 10.1126/science.1188015. |
| 26140362 | Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer. | Oncotarget | 2015 Sep 15 | Goswami MT | - |
| 21325052 | Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. | Proc Natl Acad Sci U S A | 2011 Mar 8 | Sun Q | doi: 10.1073/pnas.1014769108 |
| 20592362 | The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer. | Anticancer Res | 2010 May | Benesch C | - |
| 25576919 | Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma. | Oncotarget | 2015 Feb 10 | Chen Z | - |
| 25041845 | PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells. | Cell Signal | 2014 Nov | Wu H | doi: 10.1016/j.cellsig.2014.07.024 |
| 26876154 | Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1. | Sci Rep | 2016 Feb 15 | He CL | doi: 10.1038/srep21524. |
| 25708858 | Regulation of pyruvate kinase isozyme M2 is mediated by the ubiquitin-specific protease 20. | Int J Oncol | 2015 May | Kim SR | doi: 10.3892/ijo.2015.2901 |
| 26617865 | Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value. | Int J Clin Exp Pathol | 2015 Sep 1 | Cui R | - |
| 23212076 | Dual roles of PKM2 in cancer metabolism. | Acta Biochim Biophys Sin (Shanghai) | 2013 Jan | Wu S | doi: 10.1093/abbs/gms106 |
| 26715276 | Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer. | Tumour Biol | 2016 Jun | Dong T | doi: 10.1007/s13277-015-4729-8 |
| 25964202 | Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer. | Mol Cancer Ther | 2015 Jul | Talekar M | doi: 10.1158/1535-7163.MCT-15-0100 |
| 18337815 | Pyruvate kinase M2 is a phosphotyrosine-binding protein. | Nature | 2008 Mar 13 | Christofk HR | doi: 10.1038/nature06667. |
| 26339369 | Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer. | Int J Clin Exp Pathol | 2015 Jul 1 | Lin Y | - |
| 24795025 | SAICAR binding activates PKM2 protein kinase activity. | Cancer Discov | 2014 May | - | doi: 10.1158/2159-8290.CD-RW2014-062 |
| 25444918 | Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo. | Cancer Lett | 2015 Jan 28 | Meng MB | doi: 10.1016/j.canlet.2014.11.016 |
| 23071357 | Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells. | Clin Cancer Res | 2012 Oct 15 | Tamada M | doi: 10.1158/1078-0432.CCR-12-0859. |
| 24626155 | Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms. | PLoS One | 2014 Mar 13 | Liu J | doi: 10.1371/journal.pone.0091606 |
| 22236875 | Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth. | Cancer Biol Ther | 2011 Dec 15 | Chiavarina B | doi: 10.4161/cbt.12.12.18703 |
| 12820337 | Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer. | Anticancer Res | 2003 Mar-Apr | L??ftner D | - |
| 20082317 | Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line. | J Cell Biochem | 2010 Mar 1 | Li SL | doi: 10.1002/jcb.22413. |
| 23130662 | Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology. | J Drug Target | 2013 Feb | Shashni B | doi: 10.3109/1061186X.2012.736998 |
| 21620138 | Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. | Cell | 2011 May 27 | Luo W | doi: 10.1016/j.cell.2011.03.054. |
| 24747424 | Pyruvate kinase M2 and cancer: an updated assessment. | FEBS Lett | 2014 Aug 19 | Iqbal MA | doi: 10.1016/j.febslet.2014.04.011 |
| 24884829 | Changes in PKM2 associate with prostate cancer progression. | Cancer Invest | 2014 Aug | Wong N | doi: 10.3109/07357907.2014.919306 |
| 27040384 | Tanshinone ??A inhibits human esophageal cancer cell growth through miR-122-mediated PKM2 down-regulation. | Arch Biochem Biophys | 2016 May 15 | Zhang HS | doi: 10.1016/j.abb.2016.03.031 |
| 28347237 | Specific tumor-derived CCL2 mediated by pyruvate kinase M2 in colorectal cancer cells contributes to macrophage recruitment in tumor microenvironment. | Tumour Biol | 2017 Mar | Zou K | doi: 10.1177/1010428317695962. |
| 28641694 | [MiR-133b Affect the Proliferation and Drug Sensitivity in A549 Lung Cancer Stem Cells by Targeting PKM2]. | Zhongguo Fei Ai Za Zhi | 2017 Jun 20 | Mi Y | doi: 10.3779/j.issn.1009-3419.2017.06.02. |
| 28393220 | Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2. | Int J Oncol | 2017 May | Shang D | doi: 10.3892/ijo.2017.3950 |
| 27197174 | SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth. | Cancer Res | 2016 Jul 1 | Park SH | doi: 10.1158/0008-5472.CAN-15-2498 |
| 27385486 | Mutant p53 and mTOR/PKM2 regulation in cancer cells. | IUBMB Life | 2016 Sep | Dando I | doi: 10.1002/iub.1534 |
| 28418088 | RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells. | Mol Carcinog | 2017 Nov | Zhou C | doi: 10.1002/mc.22663 |
| 27683215 | Limited Clinical Significance of Dimeric Form of Pyruvate Kinase as a Diagnostic and Prognostic Biomarker in Non-small Cell Lung Cancer. | Adv Exp Med Biol | 2017 | Rzechonek A | doi: 10.1007/5584_2016_92. |
| 28994148 | LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2. | Cell Prolif | 2017 Dec | Wang X | doi: 10.1111/cpr.12395 |
| 29032577 | Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer. | Cancer Sci | 2017 Dec | Kitayama K | doi: 10.1111/cas.13421 |
| 28543190 | Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells. | J Cell Biochem | 2017 Dec | Yan XL | doi: 10.1002/jcb.26148 |
| 27989750 | The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition. | Free Radic Biol Med | 2016 Dec | Brandi J | doi: 10.1016/j.freeradbiomed.2016.10.499 |
| 29277786 | Correlation of Pyruvate Kinase M2 Expression with Clinicopathological Data in Ovarian Cancer. | Anticancer Res | 2018 Jan | Kobierzycki C | - |
| 27911861 | Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis. | Oncotarget | 2017 Jan 3 | Zhu H | doi: 10.18632/oncotarget.13703. |
| 29225125 | Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells. | Arch Biochem Biophys | 2018 Jan 15 | Shimada N | doi: 10.1016/j.abb.2017.12.008 |
| 28415668 | MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer. | Oncotarget | 2017 Apr 25 | Guo M | doi: 10.18632/oncotarget.15999. |
| 28380434 | iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer. | Oncotarget | 2017 May 16 | Li L | doi: 10.18632/oncotarget.16523. |
| 27283076 | Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer. | Sci Rep | 2016 Jun 10 | Lu W | doi: 10.1038/srep26351. |
| 29094170 | miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer. | Oncol Rep | 2017 Sep | Ling Z | doi: 10.3892/or.2017.5852 |
| 29229835 | O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect. | Proc Natl Acad Sci U S A | 2017 Dec 26 | Wang Y | doi: 10.1073/pnas.1704145115 |
| 29619774 | Pyruvate Kinase Isozyme M2 Plays a Critical Role in the Interactions Between Pancreatic Stellate Cells and Cancer Cells. | Dig Dis Sci | 2018 Jul | Masamune A | doi: 10.1007/s10620-018-5051-2 |
| 29752805 | Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression. | Med Sci Monit | 2018 May 12 | Zheng B | doi: 10.12659/MSM.907490. |
| 30249877 | Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway. | J Cancer Res Ther | 2018 Sep | Zhu Q | doi: 10.4103/0973-1482.187302. |
| 30279379 | SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells. | Int J Mol Sci | 2018 Oct 2 | Kuranaga Y | doi: 10.3390/ijms19103012. |
| 29408265 | Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress. | Cancer Lett | 2018 May 1 | Yang YC | doi: 10.1016/j.canlet.2018.01.075 |
